Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Mario Leoncini"'
Autor:
Francesco Bellandi, Francesco Tropeano, Mauro Maioli, Anna Toso, Simona Villani, Mario Leoncini
Publikováno v:
Cardiorenal Medicine. 10:288-301
Background/Aims: Both high-dose atorvastatin and rosuvastatin have been shown to reduce contrast-induced acute kidney injury (AKI) occurrence and improve clinical outcomes in high-risk coronary patients undergoing angiographic procedures. However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f6bebe48037843f2c60afad7f292866
https://doi.org/10.1159/000506857
https://doi.org/10.1159/000506857
Autor:
Anna Toso, Nuccia Morici, Mario Leoncini, Simona Villani, Luca A Ferri, Luigi Piatti, Daniele Grosseto, Irene Bossi, Paolo Sganzerla, Giovanni Tortorella, Michele Cacucci, Maurizio Ferrario, Stefano Tondi, Amelia Ravera, Francesco Bellandi, Claudio Cavallini, Roberto Antonicelli, Stefano De Servi, Stefano Savonitto
Publikováno v:
Age and ageing. 51(6)
Background prior statin treatment has been shown to have favourable effects on short- and long-term prognosis in patients with acute coronary syndrome (ACS). There are limited data in older patients. The aim of this study was to investigate the assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b18dfcf75c3f71ddd7d585623229da
https://pubmed.ncbi.nlm.nih.gov/35716046
https://pubmed.ncbi.nlm.nih.gov/35716046
Publikováno v:
Interventional cardiology clinics. 9(3)
Different pharmacologic agents have been tested in the effort to prevent contrast-induced acute kidney injury (AKI) in the last two decades. To date, however, no individual drug has received unanimous approval for this aim. Since 2014 statins have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1933b58d8b29a4418b948fb5666762
https://pubmed.ncbi.nlm.nih.gov/32471677
https://pubmed.ncbi.nlm.nih.gov/32471677
Autor:
Stefano Savonitto, Luca A. Ferri, Luigi Piatti, Daniele Grosseto, Giancarlo Piovaccari, Nuccia Morici, Irene Bossi, Paolo Sganzerla, Giovanni Tortorella, Michele Cacucci, Maurizio Ferrario, Ernesto Murena, Girolamo Sibilio, Stefano Tondi, Anna Toso, Sergio Bongioanni, Amelia Ravera, Elena Corrada, Matteo Mariani, Leonardo Di Ascenzo, A. Sonia Petronio, Claudio Cavallini, Giancarlo Vitrella, Renata Rogacka, Roberto Antonicelli, Bruno M. Cesana, Leonardo De Luca, Filippo Ottani, Giuseppe De Luca, Federico Piscione, Nadia Moffa, Stefano De Servi, Leonardo Bolognese, Francesco Bovenzi, Giuseppe Steffenino, Ignazio Santilli, Giorgio Bassanelli, Alice Sacco, Federico Canziani, Marco Ferri, Emilia Lo Jacono, Umberto Canosi, Giuseppe Fornaro, Mario Leoncini, Maria Rosa Conte, Rosario Farina, Catia Stefanin, Francesco Di Pede, Piersilvio Chella, M. Chiara Nardoni, Paola Tamburrini, Bruno Trimarco, Gennaro Galasso, Raffaele Elia, Simone Grotti, Lucia Borrelli, Corrado Tamburino, Piera Capranzano, Bruno Francaviglia, Carlo Campana, Roberto Bonatti, Alessandro Martinoni, Fabio Abate, Sebastian Coscarelli, Paolo Rubartelli, Giovanni Q. Villani, Roberta Rossini
Publikováno v:
Circulation. 137:2435-2445
Background: Elderly patients are at elevated risk of both ischemic and bleeding complications after an acute coronary syndrome and display higher on-clopidogrel platelet reactivity compared with younger patients. Prasugrel 5 mg provides more predicta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079de04e50f9a890f24d385a296905e7
https://doi.org/10.1161/circulationaha.117.032180
https://doi.org/10.1161/circulationaha.117.032180
Autor:
Anna Toso, Peter A. McCullough, Mario Leoncini, Mauro Maioli, Gabriele Grippo, Nicola Musilli, Claudio Ronco, Francesco Bellandi
Publikováno v:
Journal of the American College of Cardiology. 71:2880-2889
Background Intravascular volume expansion plays a major role in the prevention of contrast-induced acute kidney injury (CI-AKI). Recommended standard amounts of fluid infusion before procedures do not produce homogeneous responses in subjects with di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c486e4e1c94d471ae4ad8d0dfd25b2be
https://doi.org/10.1016/j.jacc.2018.04.022
https://doi.org/10.1016/j.jacc.2018.04.022
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 20(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86f9f2ce658d9eafc95543915569fdd
https://pubmed.ncbi.nlm.nih.gov/30222665
https://pubmed.ncbi.nlm.nih.gov/30222665
Autor:
Mauro, Maioli, Anna, Toso, Mario, Leoncini, Nicola, Musilli, Gabriele, Grippo, Claudio, Ronco, Peter A, McCullough, Francesco, Bellandi
Publikováno v:
Journal of the American College of Cardiology. 71(25)
Intravascular volume expansion plays a major role in the prevention of contrast-induced acute kidney injury (CI-AKI). Recommended standard amounts of fluid infusion before procedures do not produce homogeneous responses in subjects with different ini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a34bc2cefe2566549fd7471c7bea6c32
https://pubmed.ncbi.nlm.nih.gov/29929611
https://pubmed.ncbi.nlm.nih.gov/29929611
Autor:
Simona Villani, Francesco Tropeano, Mario Leoncini, Anna Toso, Francesco Bellandi, Emilio Di Vincenzo, Mauro Maioli
Publikováno v:
JACC: Cardiovascular Interventions. 7:1421-1429
Objectives This study sought to investigate whether the beneficial impact of high-dose rosuvastatin against contrast-induced acute kidney injury (CI-AKI) in acute coronary syndrome (ACS) patients varied in relation to baseline high-sensitivity C-reac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4868b3550ddfe2a81315461db02a8e4
https://doi.org/10.1016/j.jcin.2014.06.023
https://doi.org/10.1016/j.jcin.2014.06.023
Publikováno v:
Interventional cardiology clinics. 3(3)
In the effort to prevent contrast-induced acute kidney injury (CI-AKI), several pharmacologic agents have been tested for their single or combined nephroprotective properties. To date, however, no drug has been officially approved for this aim. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec5aa01f161e36e4721721798dfc58f3
https://pubmed.ncbi.nlm.nih.gov/28582225
https://pubmed.ncbi.nlm.nih.gov/28582225
Autor:
Francesco Bellandi, Marco Cattaneo, Mario Leoncini, Marco De Carlo, Cataldo Palmieri, Diego Maffeo, Luciana Tomasi, Diego Della Riva, Tullio Palmerini, Davide Capodanno, Paolo Calabrò, Philippe Généreux, Anna Toso, Antonio L. Bartorelli, Dominick J. Angiolillo, Federico Piscione, Chiara Barozzi, Stefano De Servi
Statin use is associated with enhanced pharmacodynamic response to clopidogrel in patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI). However, the impact of statin therapy on clopidogrel response profiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbff6882611eee5e8f1a6019336d710f
http://hdl.handle.net/20.500.11769/310999
http://hdl.handle.net/20.500.11769/310999
